Gene · 8650
Papers2,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NSrp70 suppresses metastasis in triple-negative breast cancer by modulating Numb/TβR1/EMT axis. | Oncogene | 2022 | 35568738 | PubTator, text mining | PubMed |
| WNT and NOTCH signaling in human trophoblast development and differentiation. | Cell Mol Life Sci | 2022 | 35562545 | PubTator, text mining | PubMed |
| Notch, Numb and Numb-like responses to exercise-induced muscle damage in human skeletal muscle. | Exp Physiol | 2022 | 35562322 | PubTator, text mining | PubMed |
| Aniridia-related keratopathy relevant cell signaling pathways in human fetal corneas. | Histochem Cell Biol | 2022 | 35551459 | PubTator, text mining | PubMed |
| Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review. | World J Surg Oncol | 2022 | 35538578 | PubTator, text mining | PubMed |
| Molecular determinants of αVβ5 localization in flat clathrin lattices - role of αVβ5 in cell adhesion and proliferation. | J Cell Sci | 2022 | 35532004 | PubTator, text mining | PubMed |
| Association of Low Expression of NUMB in Peripheral Blood with Acute Myocardial Infarction. | Cardiol Res Pract | 2022 | 35529060 | PubTator, text mining | PubMed |
| Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2). | NAR Cancer | 2022 | 35528200 | PubTator, text mining | PubMed |
| PDZRN4 suppresses tumorigenesis and androgen therapy-resistance in prostate cancer. | J Cancer | 2022 | 35517421 | PubTator, text mining | PubMed |
| CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of Pancreatic Cancer Cells. | J Cancer | 2022 | 35517414 | PubTator, text mining | PubMed |
| FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies. | Front Oncol | 2022 | 35515121 | PubTator, text mining | PubMed |
| TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms. | Cell Death Dis | 2022 | 35504883 | PubTator, text mining | PubMed |
| ING4 Promotes Stemness Enrichment of Human Renal Cell Carcinoma Cells Through Inhibiting DUSP4 Expression to Activate the p38 MAPK/type I IFN-Stimulated Gene Signaling Pathway. | Front Pharmacol | 2022 | 35496267 | PubTator, text mining | PubMed |
| Integrated regulation of chondrogenic differentiation in mesenchymal stem cells and differentiation of cancer cells. | Cancer Cell Int | 2022 | 35488254 | PubTator, text mining | PubMed |
| Regulatory Role of Host MicroRNAs in Flaviviruses Infection. | Front Microbiol | 2022 | 35479613 | PubTator, text mining | PubMed |
| Prognostic Biomarker NUMB Is Inhibited by Breast Cancer Cell Exosomes to Promote Breast Cancer Progression. | J Immunol Res | 2022 | 35478938 | PubTator, text mining | PubMed |
| MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer. | Front Cell Dev Biol | 2022 | 35465317 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment. | Front Oncol | 2022 | 35463320 | PubTator, text mining | PubMed |
| Exclusion of NUMB Exon12 Controls Cancer Cell Migration through Regulation of Notch1-SMAD3 Crosstalk. | Int J Mol Sci | 2022 | 35457181 | PubTator, text mining | PubMed |
| An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma. | Genes (Basel) | 2022 | 35456475 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8650/papers?page=23